Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
All voices matter
life sciences
Anthropic launches its own drug discovery program for neglected diseases
Anthropic on Tuesday unveiled Claude Science, an AI research workbench for scientists, while simultaneously announcing it will pursue its own preclinical drug discovery programs targeting neglected diseases — areas that traditional pharmaceutical companies have historically avoided.
Merck KGaA to buy Bio-Techne for $11.3 billion
Germany's Merck KGaA has reached an agreement to acquire Bio-Techne, a Minneapolis-based life sciences tools company, in a cash deal valued at approximately $11.3 billion (€9.9 billion). The offer of $73 per share represents a premium of roughly 36% over…